Clinical Trial Update: A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars. [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing Linjeta versus Humalog in insulin pumps for postprandial glucose control in diabetes mellitus was withdrawn, with no result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Humalog (insulin lispro)
• Linjeta

Snippet

Sponsor: Stanford University | Conditions: Diabetes Mellitus | Phase 2 | Status: WITHDRAWN